Year |
Citation |
Score |
2011 |
Kosloski MP, Peng A, Varma PR, Fathallah AM, Miclea RD, Mager DE, Balu-iyer SV. Immunogenicity and pharmacokinetic studies of recombinant factor VIII containing lipid cochleates. Drug Delivery. 18: 246-54. PMID 21114461 DOI: 10.3109/10717544.2010.536269 |
0.727 |
|
2009 |
Peng A, Gaitonde P, Kosloski MP, Miclea RD, Varma P, Balu-Iyer SV. Effect of route of administration of human recombinant factor VIII on its immunogenicity in Hemophilia A mice. Journal of Pharmaceutical Sciences. 98: 4480-4. PMID 19499565 DOI: 10.1002/Jps.21765 |
0.646 |
|
2009 |
Kosloski MP, Miclea RD, Balu-Iyer SV. Role of glycosylation in conformational stability, activity, macromolecular interaction and immunogenicity of recombinant human factor VIII. The Aaps Journal. 11: 424-31. PMID 19499345 DOI: 10.1208/S12248-009-9119-Y |
0.746 |
|
2008 |
Ramani K, Purohit V, Miclea R, Gaitonde P, Straubinger RM, Balu-Iyer SV. Passive transfer of polyethylene glycol to liposomal-recombinant human FVIII enhances its efficacy in a murine model for hemophilia A. Journal of Pharmaceutical Sciences. 97: 3753-64. PMID 18300296 DOI: 10.1002/Jps.21266 |
0.688 |
|
2008 |
Ramani K, Miclea RD, Purohit VS, Mager DE, Straubinger RM, Balu-Iyer SV. Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A. Journal of Pharmaceutical Sciences. 97: 1386-98. PMID 17705286 DOI: 10.1002/Jps.21102 |
0.789 |
|
2007 |
Miclea RD, Varma PR, Peng A, Balu-Iyer SV. Development and characterization of lipidic cochleate containing recombinant factor VIII. Biochimica Et Biophysica Acta. 1768: 2890-8. PMID 17936245 DOI: 10.1016/J.Bbamem.2007.08.001 |
0.776 |
|
2007 |
Miclea RD, Purohit VS, Balu-Iyer SV. O-phospho-L-serine, multi-functional excipient for B domain deleted recombinant factor VIII. The Aaps Journal. 9: E251-9. PMID 17907766 DOI: 10.1208/Aapsj0902028 |
0.745 |
|
2005 |
Ramani K, Purohit VS, Miclea RD, Middaugh CR, Balasubramanian SV. Lipid binding region (2303-2332) is involved in aggregation of recombinant human FVIII (rFVIII) Journal of Pharmaceutical Sciences. 94: 1288-1299. PMID 15858858 DOI: 10.1002/Jps.20340 |
0.474 |
|
Show low-probability matches. |